Updated safety evaluation of the food enzyme catalase from the non‐genetically modified Aspergillus tubingensis strain AE‐CN Authors: EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L M Solano, Henk Van Loveren, Laurence Vernis, Simone Lunardi, Magdalena Andryszkiewicz, Daniele Cavanna, Ana Criado, Yi Liu Published: 2026 ABSTRACT AbstractThe food enzyme catalase (hydrogen‐peroxide:hydrogen‐peroxide oxidoreductase; EC 1.11.1.6) is produced with the non‐genetically modified Aspergillus tubingensis strain AE‐CN by Amano Enzyme Inc. The food enzyme is intended to be used in seven food manufacturing processes. In a previous evaluation, the Panel could not conclude on the safety of this food enzyme due to uncertainties about the absence of viable cells of the production organism in the food enzyme and to the clastogenic effects observed in the in vitro genotoxicity studies, which could not be dismissed due to limitations in the in vivo studies. In this assessment, the Panel evaluated new data provided by the applicant and completed the safety evaluation of this food enzyme. The new data demonstrated the absence of viable cells of the production organism in the food enzyme and showed no concerns on genotoxicity. Based on the new data provided and the previous evaluation, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.Keywords: Aspergillus tubingensis, catalase, EC 1.11.1.6, EFSA‐Q‐2015‐00449, Food enzyme, hydrogen‐peroxide:hydrogen‐peroxide oxidoreductase INTRODUCTION Article 3 of the Regulation (EC) No 1332/2008 1 provides definition for ‘food enzyme’ and ‘food enzyme preparation’. ‘Food enzyme’ means a product obtained from plants, animals or micro‐organisms or products thereof including a product obtained by a fermentation process using micro‐organisms: (i) containing one or more enzymes capable of catalysing a specific biochemical reaction; and (ii) added to food for a technological purpose at any stage of the manufacturing, processing, preparation, treatment, packaging, transport or storage of foods. ‘Food enzyme preparation’ means a formulation consisting of one or more food enzymes in which substances such as food additives and/or other food ingredients are incorporated to facilitate their storage, sale, standardisation, dilution or dissolution. Before January 2009, food enzymes other than those used as food additives were not regulated or were regulated as processing aids under the legislation of the Member States. On 20 January 2009, Regulation (EC) No 1332/2008 on food enzymes came into force. This Regulation applies to enzymes that are added to food to perform a technological function in the manufacture, processing, preparation, treatment, packaging, transport or storage of such food, including enzymes used as processing aids. Regulation (EC) No 1331/2008 2 established the European Union (EU) procedures for the safety assessment and the authorisation procedure of food additives, food enzymes and food flavourings. The use of a food enzyme shall be authorised only if it is demonstrated that: it does not pose a safety concern to the health of the consumer at the level of use proposed; it does not pose a safety concern to the health of the consumer at the level of use proposed; there is a reasonable technological need; there is a reasonable technological need; its use does not mislead the consumer. its use does not mislead the consumer. All food enzymes currently on the European Union market and intended to remain on that market, as well as all new food enzymes, shall be subjected to a safety evaluation by the European Food Safety Authority (EFSA) and approval via an EU Community list. Background and Terms of Reference as provided by the requestor Background as provided by the European Commission Only food enzymes included in the Union list may be placed on the market as such and used in foods, in accordance with the specifications and conditions of use provided for in Article 7(2) of Regulation (EC) No 1332/2008 on food enzymes1. On 31 March 2025, a new application was submitted by “Amano Enzyme Inc.” seeking authorisation for the food enzyme Catalase from non‐genetically modified Aspergillus tubingensis (strain AE‐CN). This application is a follow‐up of an inconclusive opinion adopted by EFSA on 25 October 2023 (EFSA‐Q‐2015‐00449). The new application contains additional studies to address the data gaps identified in the published opinion. In accordance with the requirements of Article 12(1) of Regulation (EC) No 234/2011 implementing Regulation (EC) No 1331/2008, the Commission has verified that the application falls within the scope of the food enzyme Regulation and contains all the elements required under Chapter II of that Regulation. Terms of Reference The Commission requests the European Food Safety Authority (EFSA) to verify the requirements of Article 32b of Regulation (EC) No 178/2002, whether the suitability of the new data is in line with the requirements of Article 12(2) of Regulation (EU) No 234/2011. The Commission also requests EFSA to carry out the safety assessment and the assessment of possible confidentiality requests on the new data for the following food enzyme Catalase from non‐genetically modified Aspergillus tubingensis (strain AE‐CN), in accordance with Regulation (EC) No 1331/2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings.2 Interpretation of the Terms of Reference The applicant submitted previously an application for catalase from the non‐genetically A. tubingensis strain AE‐CN, for which EFSA could not conclude on the safety, due to uncertainties (EFSA CEP Panel, 2023a). As a follow‐up, the applicant submitted new data. The present opinion assesses the new studies provided and updates the safety evaluation of the food enzyme. Whenever previous evaluation remains unchanged, reference to the previous EFSA opinion is made. DATA AND METHODOLOGIES Data The applicant has submitted a revised dossier in support of the application for authorisation of the food enzyme catalase from a non‐genetically modified A. tubingensis strain AE‐CN. Additional information were requested during the risk assessment phase. See https://open.efsa.europa.eu/dossier/FEN‐2022‐10530. Methodologies The assessment was conducted in line with the principles described in the EFSA ‘Guidance on transparency in the scientific aspects of risk assessment’ (EFSA, 2009) and following the relevant guidance documents of the EFSA Scientific Committee. The ‘Scientific Guidance for the submission of dossiers on food enzymes’ (EFSA CEP Panel, 2021) and the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023b) have been followed for the evaluation of the application. Public consultation According to Article 32c(2) of Regulation (EC) No 178/2002 3 and to the Decision of EFSA's Executive Director laying down the practical arrangements on pre‐submission phase and public consultations, EFSA carried out a public consultation on the non‐confidential version of the technical dossier from 11 September to 02 October 2025 for which no comments were received. ASSESSMENT Systematic nameHydrogen‐peroxide:hydrogen‐peroxide oxidoreductaseSynonymsCatalase‐peroxidaseIUBMB NoEC 1.11.1.6CAS No9001‐05‐2EINECS No232‐577‐1 Catalases catalyse the decomposition of hydrogen peroxide, converting it to water and oxygen. The food enzyme is intended to be used in seven food manufacturing processes as defined in the EFSA guidance (EFA CEP Panel, 2023b): (1) processing of dairy products for the production of cheese; (2) processing of egg and egg products; processing of meat and fish products for the production of (3) modified meat and fish products (fish roe only) and (4) protein hydrolysates from meat and fish (gelatine only); processing of grains for the production of (5) baked products and (6) cereal‐based products other than baked; (7) processing of fruit and vegetables for the production of fruit and vegetable products other than juices. In a previous application (EFSA‐Q‐2015‐00449), the absence of viable cells of the production strain in the food enzyme was not demonstrated due to limitations in the study provided. Furthermore, in vitro genotoxicity studies indicated the possible presence of a clastogenic agent in the food enzyme which could not be dismissed due to limitations in the in vivo studies. Consequently, the Panel could not conclude on the safety of the food enzyme (EFSA CEP Panel, 2023a). As a follow‐up, the applicant provided new studies to test the possible presence of viable cells of the production strain in the food enzyme and new genotoxicity studies. New analyses were also conducted to characterise the purity of the food enzyme batch used for toxicological studies. Furthermore, the applicant updated the intended uses of the food enzyme. The present opinion assessed these new data provided in the application EFSA‐Q‐2025‐00275 and reaches a conclusion on the safety of the food enzyme. Source of the food enzyme See previous evaluation (EFSA CEP Panel, 2023a). Production of the food enzyme See previous evaluation (EFSA CEP Panel, 2023a). Characteristics of the food enzyme Properties of the food enzyme See previous evaluation (EFSA CEP Panel, 2023a). Chemical parameters Data on the chemical parameters of the food enzyme preparation were provided for the newly produced batch used for the bacterial reverse mutation test and in vitro mammalian cell micronucleus test (batch 4, Table 1). 4 Data on the chemical composition of the batches intended for commercialisation (batches 1–3, Table 1) were submitted in the previous application EFSA‐Q‐2015‐00449. 5 The mean total organic solids (TOS) of the three food enzyme batches intended for commercialisation was 27.6% and the mean activity activity/TOS ratio was 5186 U/mg TOS. TABLE 1Composition of the food enzyme preparation.ParametersUnitBatches1* 2* 3* 4 a Catalase activity U/g b 1,650,0001,430,0001,210,0001,230,000 Protein %32.925.223.725.7 Ash %1.21.51.61.7 Water %4.14.54.53.2■■■■■ (excipient) %61.867.870.169.4 Total organic solids (TOS) c %32.926.223.825.7 Activity/TOS ratio U/mg TOS5015545850844786 a Batch used for bacterial reverse mutation test, in vitro mammalian cell micronucleus test. b U: Unit ‐ See previous evaluation of application EFSA‐Q‐2015‐00449 (EFSA CEP Panel, 2023a, 2023b). c TOS calculated as 100% – % water – % ash – % excipient.*Commercial batches provided in the application EFSA‐Q‐2015‐00449 (EFSA CEP Panel, 2023a, 2023b). Composition of the food enzyme preparation. Batch used for bacterial reverse mutation test, in vitro mammalian cell micronucleus test. U: Unit ‐ See previous evaluation of application EFSA‐Q‐2015‐00449 (EFSA CEP Panel, 2023a, 2023b). TOS calculated as 100% – % water – % ash – % excipient. Commercial batches provided in the application EFSA‐Q‐2015‐00449 (EFSA CEP Panel, 2023a, 2023b). Purity For batches 1–3 (Table 1), see previous evaluation (EFSA‐Q‐2015‐00449). The lead content in batch 4 (Table 1) was below 5 mg/kg 6 , 7 which complies with the specification for lead as laid down in the general specifications for enzymes used in food processing (FAO/WHO, 2006). The food enzyme preparation complies with the microbiological criteria for total coliforms, Escherichia coli and Salmonella, as laid down in the general specifications for enzymes used in food processing (FAO/WHO, 2006). 8 No antimicrobial activity was detected in any of the tested batches. 9 Strains of the Aspergillus species, in common with most filamentous fungi, have the capacity to produce a range of secondary metabolites (Frisvad et al., 2018). The presence of aflatoxins (B1, B2, G1, G2), fumonisins (B1, B2), deoxynivalenol, ochratoxin A, sterigmatocystin, T2‐toxin and HT2‐toxin, and zearalenone was examined in the batch used for toxicological testing and all were below the limit of detection (LoD) of the applied methods. 10 , 11 Adverse effects caused by the possible presence of other secondary metabolites are addressed by the toxicological examination of the food enzyme. The Panel considered that the information provided on the purity of the food enzyme was sufficient. Viable cells of the production strain Previous data on the absence of viable cells of the production strain in the food enzyme showed the presence of some colonies that were not discriminated from the production strain. Furthermore, no adequate positive control was included in the analysis. Based on this, the Panel concluded that the absence of viable cells from the production strain was not demonstrated (EFSA CEP Panel, 2023a). The applicant has now provided new studies to demonstrate the absence of viable cells of the production strain in the food enzyme in three independent batches analysed in triplicate. ■■■■■ No colonies were detected. A positive control was included. 12 Toxicological data The EFSA CEP Panel (2023a) evaluated in vitro and in vivo genotoxicity studies submitted for the safety evaluation of the food enzyme catalase from the non‐genetically modified A. tubingensis strain AE‐CN. The food enzyme did not induce gene mutations in bacteria in the presence or absence of metabolic activation (S9‐mix). However, in two in vitro studies, an increased frequency of structural chromosomal aberrations and of bi‐nucleated cells with micronuclei (MNBN) were observed in the presence of S9‐mix. Follow‐up in vivo genotoxicity studies were inconclusive, because the exposure of target organs was not demonstrated and the highest dose administered was not a maximum tolerated dose (MTD) or achievable dose. Based on this, the Panel concluded that the possible presence of a clastogenic agent in the food enzyme could not be excluded (EFSA CEP Panel, 2023a). In 2025, the applicant provided two new in vitro genotoxicity tests, including a bacterial reverse mutation test (Ames test) and an in vitro mammalian cell micronucleus test. The batch used in these studies (batch 4, Table 1) has lower enzyme activity/TOS ratio than the batches intended for commercialisation reported in the original opinion (EFSA CEP Panel, 2023a) and thus is considered suitable as a test item. Genotoxicity The present assessment supersedes Section 3.4.1 of the previous evaluation (EFSA CEP Panel, 2023a). Bacterial reverse mutation test A bacterial reverse mutation test (Ames test) was performed according to the Organisation for Economic Co‐operation and Development (OECD) Test Guideline 471 (OECD, 2020) and following Good Laboratory Practice (GLP). 13 Four strains of Salmonella Typhimurium (TA98, TA100, TA1535 and TA1537) and Escherichia coli WP2uvrA(pKM101) were used with or without metabolic activation (S9‐mix), applying the pre‐incubation method. A range‐finding and two main experiments were conducted in triplicate. Based on the results from the range‐finding test, the main experiments were carried out using five concentrations of the food enzyme of 313, 625, 1250, 2500 and 5000 μg TOS/plate. No cytotoxicity was observed at any concentration of the test substance. Upon treatment with the food enzyme, there was no biologically relevant increase in the number of revertant colonies above the control values, in any strain tested, with or without S9‐mix. The Panel concluded that the food enzyme catalase did not induce gene mutations under the test conditions applied in this study. In vitro mammalian cell micronucleus test The in vitro mammalian cell micronucleus test was carried out according to the OECD Test Guideline 487 (OECD, 2016) and following GLP. 14 A range‐finding test and two separate experiments were performed with duplicate cultures of a Chinese hamster lung (CHL/IU) fibroblast cell line. The cell cultures were treated with the food enzyme with or without metabolic activation (S9‐mix). Based on the results from the range‐finding test, cells were exposed to the food enzyme and scored for the frequency of MNBN at concentrations of 750, 1500 and 3000 μg TOS/mL in a short‐term treatment (6‐h exposure and 24‐h recovery period) with S9‐mix, or at concentrations of 500, 1000 and 2000 μg TOS/mL without S9‐mix. In the second experiment, cells were exposed to the food enzyme and scored for MNBN at concentrations of 650, 1300 and 2600 μg TOS/mL in a long‐term treatment (24‐h exposure without recovery period) without S9‐mix. In the short‐term treatment, cytotoxicity of 67% (based on a cytokinesis‐block proliferation index (CBPI) was observed at 3000 μg TOS/mL with S9‐mix and of 16% at 2000 μg TOS/mL), without S9‐mix. In the long‐term treatment, cytotoxicity of 33% (based on CBPI) was observed at concentration of 2600 μg TOS/mL. The frequency of MNBN was not statistically significantly different to the negative controls at any concentration tested. The Panel concluded that the food enzyme catalase did not induce an increase in the frequency of MNBN under the test conditions applied in this study. Repeated dose 90‐day oral toxicity study in rodents The Panel identified a no observed adverse effect level of 323 mg TOS/kg bw per day, the highest dose tested. See previous evaluation (EFSA CEP Panel, 2023a). Allergenicity See previous evaluation (EFSA CEP Panel, 2023a). Dietary exposure The present dietary exposure assessment supersedes Section 3.5 of the previous evaluation (EFSA CEP Panel, 2023a). Intended use of the food enzyme The food enzyme is intended to be used in seven food manufacturing processes at the revised use levels summarised in Table 2. TABLE 2Updated intended uses and use levels of the food enzyme. 15 Food manufacturing process a Raw material (RM)Recommended use level (mg TOS/kg RM)Current evaluation b Previous evaluation b , c Processing of dairy products Production of cheese Milk0.00001–0.0001 0.0003–0.001 Processing of eggs and egg productsLiquid egg, egg yolk, egg white0.08–0.8 0.004–0.03 Processing of meat and fish products Production of modified meat and fish products (fish roe only) d Fish roe 16 0.12–1.2 14–1413 Production of protein hydrolysates from meat and fish (gelatine only 17 ) d Skin from fish, cowhide, pig hide, bones etc.0.12–1.2 Processing of cereals and other grains Production of baked products Flour0.08–0.8 1–10 Production of cereal‐based products other than baked Cereals0.08–0.8 Processing of fruits and vegetables Production of fruit and vegetable products other than juices Fruit and vegetables0.03–1.2 1.4–14 Fruit peels slurry0.3Abbreviation: TOS, total organic solids. a The name has been harmonised by EFSA in accordance with the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023a, 2023b). b The numbers in bold were used for calculation. c The previous evaluation is made for the food enzyme application EFSA‐Q‐2015‐00449. d For the input table, see Appendix C. Updated intended uses and use levels of the food enzyme. 15 Production of cheese Production of cheese Production of modified meat and fish products (fish roe only) d Production of modified meat and fish products (fish roe only) d Production of protein hydrolysates from meat and fish (gelatine only 17 ) d Production of protein hydrolysates from meat and fish (gelatine only 17 ) d Production of baked products Production of baked products Production of cereal‐based products other than baked Production of cereal‐based products other than baked Production of fruit and vegetable products other than juices Production of fruit and vegetable products other than juices Abbreviation: TOS, total organic solids. The name has been harmonised by EFSA in accordance with the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023a, 2023b). The numbers in bold were used for calculation. The previous evaluation is made for the food enzyme application EFSA‐Q‐2015‐00449. For the input table, see Appendix C. The Panel noted a substantial decrease in the use levels for five food manufacturing processes, when compared to the previously recommended levels. The applicant ascribes these changes to the availability of actual use levels from food manufacturers. 18 In the production of cheese, fish roes, gelatine and fruit peel fibres, following a treatment with hydrogen peroxide, the catalase is added to the raw materials (milk, 19 fish roes, 20 side streams from meat and fish 21 and fruit peel slurry 22 respectively) to remove residual amounts of hydrogen peroxide. In the processing of eggs and egg products, 23 and in the production of baked products, 24 cereal‐based products other than baked 25 and fruit and vegetable products other than juices (e.g. concentrates), 26 the raw materials are treated with glucose oxidase and the food enzyme is added to remove the residual hydrogen peroxide. The food enzyme–TOS remain in the final foods. The food enzyme has a temperature optimum between 40°C and 60°C (pH 7.0) and a pH optimum between pH 6.0 and 8.0 (30°C). After pre‐incubation of the food enzyme for 5 min at different temperatures (pH 7.0), no residual activity was detected above 80°C (EFSA CEP Panel, 2023a). Based on these data and the downstream processing within the respective food manufacturing processes, the Panel concluded that the food enzyme is inactivated in most of the food manufacturing processes listed in Table 2. However, it may remain in its active form in baked products, fish roes and cheeses, depending on the heat treatment conditions. Dietary exposure estimation Chronic exposure to the food enzyme–TOS was calculated using the FEIM webtool 27 by combining the maximum recommended use level with individual consumption data (EFSA CEP Panel, 2021). The estimation involved selection of relevant food categories and application of technical conversion factors (EFSA CEP Panel, 2023b). The applicant provided a list of the FoodEx categories that should be considered for the exposure estimation to the production of fish roe and production of gelatine, together with their respective technical conversion factors. 28 This list has been revised by the Panel and the final outcome that was used for the exposure calculation is presented in Appendix C. Table 3 provides an overview of the derived exposure estimates across all surveys. Detailed mean and 95th percentile exposure to the food enzyme–TOS per age class, country and survey, as well as contribution from each FoodEx category to the total dietary exposure are reported in Appendix A – Tables 1 and 2. For the present assessment, food consumption data were available from 51 dietary surveys (covering infants, toddlers, children, adolescents, adults and the elderly), carried out in 27 European countries (Appendix B). The highest dietary exposure was estimated to be 0.030 mg TOS/kg bw per day in toddlers at the 95th percentile. TABLE 3Summary of the estimated dietary exposure to the food enzyme–TOS in six population groups.Population groupEstimated exposure (mg TOS/kg body weight per day)InfantsToddlersChildrenAdolescentsAdultsThe elderly Age range 4–11 months12–35 months3–9 years10–17 years18–64 years≥ 65 years Min–max mean (number of surveys)0.002–0.018 (14)0.004–0.012 (17)0.004–0.009 (21)0.001–0.006 (23)0.001–0.003 (23)0.001–0.003 (25) Min–max 95th percentile (number of surveys)0.005–0.025 (13)0.009–0.030 (16)0.008–0.023 (21)0.003–0.016 (22)0.002–0.007 (23)0.002–0.006 (24)Abbreviation: TOS, total organic solids. Summary of the estimated dietary exposure to the food enzyme–TOS in six population groups. Abbreviation: TOS, total organic solids. Uncertainty analysis In accordance with the guidance provided in the EFSA opinion related to uncertainties in dietary exposure assessment (EFSA, 2006), the following sources of uncertainties have been considered and are summarised in Table 4. TABLE 4Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate.Sources of uncertaintiesDirection of impact Model input data Consumption data: different methodologies/representativeness/underreporting/misreporting/no portion size standard+/−Use of data from food consumption surveys of a few days to estimate long‐term (chronic) exposure for high percentiles (95th percentile)+Possible national differences in categorisation and classification of food+/− Model assumptions and factors Selection of broad FoodEx categories for the exposure assessment+Exposure to food enzyme–TOS always calculated based on the recommended maximum use level+Use of recipe fractions to disaggregate FoodEx categories+/−Use of technical factors in the exposure model+/− Note: +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of exposure. Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate. Note: +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of exposure. The conservative approach applied to estimate the dietary exposure to the food enzyme–TOS, in particular assumptions made on the occurrence and use levels of this specific food enzyme, is likely to have led to an overestimation of the exposure. Margin of exposure In the previous evaluation, a margin of exposure was not calculated because of the uncertainty over genotoxicity (EFSA CEP Panel, 2023a). In the current evaluation, a comparison of the NOAEL (323 mg TOS/kg bw per day) identified from the 90‐day rat study (EFSA CEP Panel, 2023a) with the derived exposure estimates of 0.001–0.018 mg TOS/kg bw per day at the mean and from 0.002 to 0.030 mg TOS/kg bw per day at the 95th percentile resulted in a margin of exposure of at least 10,767. CONCLUSIONS Based on the new data on absence of viable cells, the new genotoxicity studies and the evaluation of the data previously submitted, the Panel concluded that the food enzyme catalase produced with the non‐genetically modified A. tubingensis strain AE‐CN does not give rise to safety concerns under the intended conditions of use. DOCUMENTATION AS PROVIDED TO EFSA Dossier and additional information can be accessed at https://open.efsa.europa.eu/dossier/FEN‐2022‐10530 ABBREVIATIONS body weight Chemical Abstracts Service cytokinesis‐block proliferation index EFSA Panel on Food Contact Materials, Enzymes and Processing Aids European Inventory of Existing Commercial Chemical Substances Food and Agricultural Organization of the United Nations Good Laboratory Practice genetically modified organism International Union of Biochemistry and Molecular Biology kiloDalton limit of quantification bi‐nucleated cells with micronuclei margin of exposure Organisation for Economic Cooperation and Development total organic solids World Health Organization REQUESTOR European Commission QUESTION NUMBER EFSA‐Q‐2025‐00275 COPYRIGHT FOR NON‐EFSA CONTENT EFSA may include images or other content for which it does not hold copyright. In such cases, EFSA indicates the copyright holder and users should seek permission to reproduce the content from the original source. PANEL MEMBERS José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize de Lourdes Marzo Solano, Henk Van Loveren, Laurence Vernis, and Holger Zorn. LEGAL NOTICE The published scientific output implements EFSA's decision on the confidentiality requests submitted on specific information items. Information items awarded confidential status by EFSA and included in the relevant scientific output have been withheld from public disclosure by redaction. Supporting information APPENDIX A Dietary exposure estimates to the food enzyme–TOS in details Dietary exposure estimates to the food enzyme–TOS in details Appendix A can be found in the online version of this output (in the ‘Supporting information’ section). The file contains two sheets, corresponding to two tables. Table 1: Average and 95th percentile exposure to the food enzyme–TOS per age class, country and survey. Table 2: Contribution of food categories to the dietary exposure to the food enzyme–TOS per age class, country and survey. Population groups considered for the exposure assessment PopulationAge rangeCountries with food consumption surveys covering more than 1 day Infants From 16 weeks on up to and including 11 months of ageBulgaria, Croatia, Cyprus, Denmark, Estonia, Finland, France, Germany, Italy, Latvia, Poland, Portugal, Slovenia, Spain Toddlers From 12 months up to and including 35 months of ageBelgium, Bulgaria, Croatia, Cyprus, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Latvia, Montenegro*, Netherlands, Poland, Portugal, Republic of North Macedonia*, Serbia*, Slovenia, Spain Children From 36 months up to and including 9 years of ageAustria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, Montenegro*, Netherlands, Poland, Portugal, Republic of North Macedonia*, Serbia*, Spain, Sweden Adolescents From 10 years up to and including 17 years of ageAustria, Belgium, Bosnia and Herzegovina*, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, Montenegro*, Netherlands, Poland, Portugal, Romania, Serbia*, Slovenia, Spain, Sweden Adults From 18 years up to and including 64 years of ageAustria, Belgium, Bosnia and Herzegovina*, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Montenegro*, Netherlands, Poland, Portugal, Romania, Serbia*, Slovenia, Spain, Sweden The elderly a From 65 years of age and olderAustria, Belgium, Croatia, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Montenegro*, Netherlands, Poland, Portugal, Romania, Serbia*, Slovenia, Spain, Sweden*Consumption data from these pre‐accession countries are not reported in Table 2 of this opinion, however, they are included in Appendix A for testing purpose. a The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’ in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment’ (EFSA, 2011). Consumption data from these pre‐accession countries are not reported in Table 2 of this opinion, however, they are included in Appendix A for testing purpose. The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’ in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment’ (EFSA, 2011). FoodEx2 categories and technical conversion factors considered for food manufacturing processes not included in the EFSA guidance TABLE C.1 Input table used to estimate the exposure to the “Production of modified meat and fish products (fish roe only)”.FoodEx_codeFoodEx_nameFoodEx hierarchical levelTf1Tf2Tf3A02EMFish roe (unspecified)Fish roe3111 TABLE C.1 Input table used to estimate the exposure to the “Production of modified meat and fish products (fish roe only)”. TABLE C.2 Input table used to estimate the exposure to the “Production of protein hydrolysates from meat and fish (gelatine only)”.FoodEx_codeFoodEx_nameFoodEX hierarchical levelTf1Tf2Tf3A0F5EGelatine751.0001.00A00ARCheese cake (unspecified)750.0100.45A00ASCream cheese cake750.0100.45A00ATCheese cream sponge cake750.0100.45A00AVCream cake (unspecified)750.0100.45A00AXCream custard cake750.0100.45A00AYCream custard sponge cake750.0100.45A00BAFruit cake750.0100.45A00BNCroissant, filled with chocolate750.0100.45A00BPCroissant, filled with cream750.0100.45A00BQCroissant, filled with jam750.0100.45A00BXFlan tart (unspecified)750.0100.45A00BYRhubarb flan750.0100.45A00BZFruit pie‐tarts750.0100.45A00CGCream‐cheese strudel750.0100.45A00EYCereal bars (unspecified)750.1000.03A00EZCereal bars plain750.1000.03A00FACereal bars mixed750.1000.03A026JMeat specialties (unspecified)750.0501.00A026KMeat‐based spreadable‐textured specialities (unspecified)750.0501.00A026LMeat spread750.0501.00A026MLiver‐based spreadable‐textured specialities (unspecified)750.0100.05A02NEYoghurt (unspecified)750.0050.05A02NFYoghurt, cow milk (unspecified)750.0050.05A02NGYoghurt, cow milk, plain750.0050.05A02NHYoghurt, cow milk, flavoured750.0050.05A02NJYoghurt, sheep milk (unspecified)750.0050.05A02NKYoghurt, sheep milk, plain750.0050.05A02NLYoghurt, sheep milk, flavoured750.0050.05A02NMYoghurt, goat milk (unspecified)750.0050.05A02NNYoghurt, goat milk, plain750.0050.05A02NPYoghurt, goat milk, flavoured750.0050.05A02QAIce cream, milk‐based750.2000.05A02QBIce cream, milk‐imitate based (unspecified)750.2000.05A02QBIce cream, milk‐imitate based750.2000.05A02QMSkyr750.0050.05A034SPralines750.0200.36A035HFoamed sugar products (marshmallows)750.0301.00A035JLiquorice candies750.0201.00A035KGum drops750.1001.00A035LJelly candies750.1001.00A036HGelatine dessert750.0301.00A03SKVitamin and mineral supplements (unspecified)750.2000.50A03SPMiscellaneous supplements or nutraceuticals (unspecified)750.2000.50A03SQBee‐produced formulations750.2000.50A03SRFibre supplements750.2000.50A03STAlgae‐based formulations (e.g. Spirulina, chlorella)750.2000.50A03SVOther common supplements750.2000.50A03SXFormulations containing special fatty acids (e.g. Omega‐3, essential fatty acids)750.2000.50A03SZCoenzyme q10 formulations750.2000.50A03TAEnzyme‐based formulations750.2000.50A03TBYeast‐based formulations750.2000.50A03TCMixed supplements/formulations750.2000.50A03VGPrepared potato salad750.2000.20A03VZMeat in aspic750.0500.50A03XAMeat loaf750.0500.50A03XBPork meat loaf750.0500.50A03XCBeef loaf750.0500.50A03XDMeat loaf with cheese, vegetables or other750.0500.50A042HPrepared pasta salad750.2000.20A0ERSweet bars and other formed sweet masses (unspecified)750.2000.03 TABLE C.2 Input table used to estimate the exposure to the “Production of protein hydrolysates from meat and fish (gelatine only)”. EFSA FEZ Panel (EFSA Panel on Food Enzymes) , Zorn, H. , Barat Baviera, J. M. , Bolognesi, C. , Catania, F. , Gadermaier, G. , Greiner, R. , Mayo, B. , Mortensen, A. , Roos, Y. H. , Solano, M. L. M. , Van Loveren, H. , Vernis, L. , Lunardi, S. , Andryszkiewicz, M. , Cavanna, D. , Criado, A. , & Liu, Y. (2026). Updated safety evaluation of the food enzyme catalase from the non‐genetically modified Aspergillus tubingensis strain AE‐CN . EFSA Journal, 24(5), e10082. 10.2903/j.efsa.2026.10082 Adopted: 14 April 2026 Correspondence: Ask a Question The declarations of interest of all scientific experts active in EFSA's work are available at https://open.efsa.europa.eu/experts. Notes Regulation (EC) No 1332/2008 of the European Parliament and of the Council of 16 December 2008 on Food Enzymes and Amending Council Directive 83/417/EEC, Council Regulation (EC) No 1493/1999, Directive 2000/13/EC, Council Directive 2001/112/EC and Regulation (EC) No 258/97. OJ L 354, 31.12.2008, pp. 7–15. Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings. OJ L 354, 31.12.2008, pp. 1–6. Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. OJ L 31, 1.2.2002, p. 1–24. Technical dossier/p. 3/Toxicological data/Genotoxicity/Annex 4–3 Certificate of analysis/Methods of Analysis/Annex 4–1 Assay methods. Technical dossier EFSA‐Q‐2015‐00449/p. 36/Annex 3. Technical dossier/p. 3/Toxicological data/Genotoxicity/Annex 4–3 Certificate of analysis/Methods of Analysis/Annex 4–1 Assay methods. LoQ: Pb = 5 mg/kg. Technical dossier/p. 3/Toxicological data/Genotoxicity/Annex 4–3 Certificate of analysis/Methods of Analysis/Annex 4–1 Assay methods. Technical dossier/p. 3/Toxicological data/Genotoxicity/Annex 4–3 Certificate of analysis/Methods of Analysis/Annex 4–1 Assay methods. LoQs: aflatoxins (B1, B2, G1 and G2) = 1 μg/kg each; fumonisins (B1, B2) = 50 μg/kg each; deoxynivalenol = 50 μg/kg; ochratoxin A = 5 μg/kg; sterigmatocystin = 50 μg/kg; T2‐toxin = 10 μg/kg; HT2‐toxin = 50 μg/kg; zearalenone = 50 μg/kg. Technical dossier/p. 3/Toxicological data/Genotoxicity/Annex 4–3 Certificate of analysis/Methods of Analysis/Annex 4–1 Assay methods. Technical dossier/Risk assessment/Source of the food enzyme/Annex 1. Technical dossier/Toxicological data/Genotoxicity/Annex 2–1. Technical dossier/Toxicological data/Genotoxicity/Annex 3–1. Technical dossier/Intended use(s) in food and use level(s) (Proposed normal and maximum use levels)/4–11 Proposed conditions of use.AE‐CN/p. 4. Additional information February 26/Additional information ‐ Intended uses in food and use levels_21 Jan 2026/Answer 1. Additional information February 26/Additional information ‐ Intended uses in food and use levels_21 Jan 2026/Answer 1. Technical dossier/Intended use(s) in food and use level(s) (Proposed normal and maximum use levels)/4–11 Proposed conditions of use.AE‐CN/pp. 4–5. Technical dossier/Intended use(s) in food and use level(s) (Proposed normal and maximum use levels)/Annex 5 Flow chart of each application_AE‐CN/p. 3. Technical dossier/Intended use(s) in food and use level(s) (Proposed normal and maximum use levels)/Annex 5 Flow chart of each application_AE‐CN/p. 5. Technical dossier/Intended use(s) in food and use level(s) (Proposed normal and maximum use levels)/Annex 5 Flow chart of each application_AE‐CN/p. 6. Technical dossier/Intended use(s) in food and use level(s) (Proposed normal and maximum use levels)/Annex 5 Flow chart of each application_AE‐CN/p. 8. Technical dossier/Intended use(s) in food and use level(s) (Proposed normal and maximum use levels)/Annex 5 Flow chart of each application_AE‐CN/p. 4. Technical dossier/Intended use(s) in food and use level(s) (Proposed normal and maximum use levels)/Annex 5 Flow chart of each application_AE‐CN/p. 1. Additional information February 26/Additional information ‐ Intended uses in food and use levels_21 Jan 2026/p. 3. Technical dossier/Intended use(s) in food and use level(s) (Proposed normal and maximum use levels)/Annex 5 Flow chart of each application_AE‐CN/p. 7. Version 1.1.1. Additional information February 26/Additional information Annex 1 FEIM calculation result. REFERENCES Associated Data Supplementary Materials APPENDIX A Dietary exposure estimates to the food enzyme–TOS in details